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Abstract
Background
The HIV-1 subtype B epidemic amongst men who have sex with men (MSM) is resurgent in
many countries despite the widespread use of effective combination antiretroviral therapy
(cART). In this combined mathematical and phylogenetic study of observational data, we
aimed to find out the extent to which the resurgent epidemic is the result of newly introduced
strains or of growth of already circulating strains.
Methods and Findings
As of November 2011, the ATHENA observational HIV cohort of all patients in care in the
Netherlands since 1996 included HIV-1 subtype B polymerase sequences from 5,852
patients. Patients who were diagnosed between 1981 and 1995 were included in the cohort
if they were still alive in 1996. The ten most similar sequences to each ATHENA sequence
were selected from the Los Alamos HIV Sequence Database, and a phylogenetic tree was
created of a total of 8,320 sequences. Large transmission clusters that included10
ATHENA sequences were selected, with a local support value 0.9 and median pairwise
patristic distance below the fifth percentile of distances in the whole tree. Time-varying
reproduction numbers of the large MSM-majority clusters were estimated through
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mathematical modeling. We identified 106 large transmission clusters, including 3,061
(52%) ATHENA and 652 Los Alamos sequences. Half of the HIV sequences from MSM reg-
istered in the cohort in the Netherlands (2,128 of 4,288) were included in 91 large MSM-
majority clusters. Strikingly, at least 54 (59%) of these 91 MSM-majority clusters were
already circulating before 1996, when cART was introduced, and have persisted to the
present. Overall, 1,226 (35%) of the 3,460 diagnoses among MSM since 1996 were found
in these 54 long-standing clusters. The reproduction numbers of all large MSM-majority
clusters were around the epidemic threshold value of one over the whole study period. A
tendency towards higher numbers was visible in recent years, especially in the more
recently introduced clusters. The mean age of MSM at diagnosis increased by 0.45 years/
year within clusters, but new clusters appeared with lower mean age. Major strengths of this
study are the high proportion of HIV-positive MSM with a sequence in this study and the
combined application of phylogenetic and modeling approaches. Main limitations are the
assumption that the sampled population is representative of the overall HIV-positive popula-
tion and the assumption that the diagnosis interval distribution is similar between clusters.
Conclusions
The resurgent HIV epidemic amongst MSM in the Netherlands is driven by several large,
persistent, self-sustaining, and, in many cases, growing sub-epidemics shifting towards
new generations of MSM. Many of the sub-epidemics have been present since the early
epidemic, to which new sub-epidemics are being added.
Introduction
The HIV-1 epidemic amongst men who have sex with men (MSM) is resurgent in many West-
ern countries [1–5]. This may seem paradoxical, as HIV-positive men are being diagnosed at
an increasingly earlier stage of HIV infection, and, since 1996, most diagnosed men take effec-
tive combination antiretroviral therapy (cART). Not only does successful therapy halt disease
progression [6], but successful suppression of virus replication also reduces the risk of trans-
mitting HIV [7,8]. With the introduction of cART, however, there has been an increase in
unprotected sex in many countries. For the Netherlands, this was first demonstrated using a
mathematical model that included disease progression to analyze national data from the
ATHENA cohort on HIV and AIDS diagnoses and treatment success and failure [1,2]. These
findings were later confirmed by analysis of behavioral data from the Amsterdam Cohort Stud-
ies, which found that sexual risk behavior increased in a manner similar to model predictions
[9,10]. The resulting reproduction number for the epidemic amongst MSM was estimated to
be around the epidemic threshold of one [2]. In the period 2007–2010, 2,928 new HIV diagno-
ses were registered amongst MSM in the Netherlands, very similar to earlier predictions assum-
ing no reductions in risk behavior [2].
In the current study, we aimed to gain more insight into the transmission clusters that con-
stitute this mainly HIV-1 subtype B epidemic amongst MSM over time [11]. Similarly to an
earlier Swiss study, we used phylogenetic analysis of extensive HIV-1 subtype B polymerase
(pol) sequence data to identify large transmission clusters [12]. The authors of the Swiss study
subsequently estimated a reproduction number for each sub-epidemic directly from the
sequence data [13,14]. Here, we also analyze the viral transmission dynamics over time within
HIV-1 Transmission Dynamics
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the different clusters. However, we applied a mathematical model to the estimated incidence of
diagnoses within each cluster, using the distribution of time between diagnoses of index cases
and secondary cases derived from a previous study [2,15]. Our analysis estimates the time-
varying reproduction numbers of the large MSM-majority clusters that together drive the over-
all dynamics of the epidemic. This will clarify the extent to which the resurgent epidemic is the
result of newly introduced strains or of growth of already circulating strains.
Methods
The methods used in this study, along with the underlying assumptions, are summarized in
Fig 1 and explained in detail below and in S1 Text.
Patient Cohort
The ATHENA national observational HIV cohort includes anonymized data from all HIV-
infected patients followed longitudinally in the 27 HIV treatment centers, in the Netherlands
since 1 January 1996 and in the St. Elisabeth Hospital in Willemstad, Curaçao, since 1 January
2005, except 1.5% who opt out [16]. Patients who were diagnosed between 1981 and 1995 were
included in the cohort if they were still alive in 1 January 1996 [2]. Demographic data were col-
lected at entry in the cohort, including self-reported most likely risk group of infection, and
most likely country of infection. Population-based nucleotide HIV-1 partial pol gene sequences
were obtained as part of the screening for resistance to antiretroviral drugs, either before start
of cART or at the time of virological failure, sometimes retrospectively, as described in detail
previously [11,17]. Subtype B sequences were identified by phylogenetic analysis using refer-
ence sequences from the Los Alamos HIV Sequence Database [18]. As of 1 November 2011,
the ATHENA cohort included 19,095 HIV-1-infected patients, of whom 7,589 (40%) had at
least one sequence; 5,852 (77%) patients were infected with a subtype B strain.
At initiation, the ATHENA observational cohort was approved by the institutional review
boards of all participating centers. It has subsequently become an integral part of HIV care and
includes anonymized data and stored plasma samples from HIV-infected patients living in the
Netherlands and receiving care in one of the designated HIV treatment centers. Patients can
opt out after being informed by their treating physician of the purpose of collection of data and
samples. Data from patients who opt out are not included in the ATHENA database. Anon-
ymized data may be used for scientific purposes without further review. Patients are informed
that if there are future requests for use of stored plasma samples for scientific research, they
will be asked for prior consent by their treating HIV physician. Data are anonymized before
being provided to investigators. For the purpose of our analysis, only existing data have been
used, and therefore no additional review or consent has been necessary.
Recent HIV-1 Infections
Recent HIV-1 infections were defined as infections with either (i) a seroconversion interval of
18 mo or less between the last negative and the first positive HIV-1 serology test or (ii) a diag-
nosis of primary HIV-1 infection defined as detectable HIV-1 RNA in plasma, detectable
serum p24 antigen in plasma, or both, combined with either a negative HIV-1 antibody test or
a positive HIV-1 antibody test with a negative or indeterminate HIV-1 Western blot.
Patient Sequences in a Phylogenetic Context
A phylogenetic context for the HIV sequences in our patient cohort was provided by sequences
that were selected from the Los Alamos HIV Sequence Database [18]. As of 15 March 2013,
HIV-1 Transmission Dynamics
PLOSMedicine | DOI:10.1371/journal.pmed.1001898 November 3, 2015 3 / 25
Fig 1. Flow diagram describing the methods and underlying assumptions.
doi:10.1371/journal.pmed.1001898.g001
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there were 56,643 subtype B sequences, one per patient, of minimal length 500, with a known
country of sampling that was not the Netherlands. Sixteen sequences from Suriname were
added from a previous study [19]. For each of the 5,852 subtype B sequences in our dataset, the
ten most similar sequences were identified by BLAST 2.2.22+ [20]. In total, 2,468 unique
sequences were added to the study.
Sequence Alignment
A total of 8,320 unique sequences were aligned using Clustal Omega 1.1.0 [21] and manually
checked and adjusted. Gblocks 0.91b was used to define the optimal sequence length of consis-
tently aligned positions at 1,254 nucleotides [22]. Major resistance-conferring sites at the
amino acid positions described by the International AIDS Society–USA were excluded for phy-
logenetic analysis, including alternative substitutions at position 215 and two insertions [23],
resulting in an alignment length of 1,137 nucleotides.
Transmission Clusters
A phylogenetic tree was built in FastTree 2.1.3 using a general time-reversible(GTR) model
[24]. PhyloPart 2.0 was used to define transmission clusters as those clusters of sequences with
a local support value 0.9 based on 1,000 resamples and for which the median value of all
pairwise patristic distances of the sub-tree was below the fifth percentile threshold of the distri-
bution of all pairwise distances of the whole tree [25], which corresponded to 0.068 mutations
per site. We considered only large national transmission clusters with sequences from at least
ten patients from within the ATHENA cohort [12]. The median of the median values of all
pairwise distances per large cluster was 0.042 (interquartile range [IQR] 0.030–0.057) muta-
tions per site. The duration of a large cluster was defined as the time between the earliest and
latest date of diagnosis within the cluster. As a sensitivity analysis, comparisons for three differ-
ent cluster definitions were made: a “looser” cluster definition, with a local support value 0.8
and with a median value of all pairwise distances under the tenth percentile threshold, a “more
stringent” cluster definition, with a local support value 0.95 and with a median value of all
pairwise distances under the 2.5th percentile threshold, and a third cluster definition, with a
local support value 0.9 and a single linkage distance threshold of 0.042 mutations/site.
Bayesian Time-Scaled Phylogenetic Analysis
We applied a Bayesian Markov chain Monte Carlo (MCMC) method as implemented in
BEAST 1.7.5 for phylogenetic analysis of time-stamped sequence data to calculate the time of
the most recent common ancestor (MRCA) of each large cluster. This value would indicate the
time point since when each cluster has been circulating in the Netherlands, and simultaneously
we confirmed the selected clusters by a different phylogenetic method. This was done by
grouping clusters together in batches of approximately 200 sequences. Sequences from the Los
Alamos HIV Sequence Database were included when the national cluster included5 time-
stamped sequences obtained in another country [26]. We used the uncorrelated log-normal
relaxed molecular clock with a discretized gamma-distributed general time-reversible substitu-
tion model and the Bayesian skyride coalescent model [27,28]. Analyses of 200 million MCMC
generations were performed, and evolutionary parameters were sampled every 20,000 genera-
tions to retrieve a distribution of posterior trees. After removing 10% of the initial output for
burn-in, convergence of the MCMC output with effective sample size above 200 was inspected
and confirmed in Tracer [29]. Maximum clade credibility (MCC) trees keeping the heights of
the target tree were obtained using TreeAnnotator 1.8.0 after discarding 10% of the posterior
trees as burn-in and were visualized using FigTree 1.4.2 [29]. Node ages and correspondent
HIV-1 Transmission Dynamics
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95% highest posterior density (HPD) intervals were taken as the time of the MRCA and corre-
sponding uncertainty estimates.
Estimation of the Time-Varying Case Reproduction Number within
Transmission Clusters
We analyzed HIV-1 transmission dynamics within each of the large transmission clusters con-
taining a majority of MSM. For each cluster, we estimated the case reproduction number for
each year t, Rt, defined as the average number of secondary cases infected by an index case diag-
nosed in year t. We used an extension of the method introduced by Wallinga and Teunis [15],
which allows estimation of Rt based on the incidence of diagnosis time series and what we call
the diagnosis interval distribution, i.e., the distribution of the time from diagnosis of an index
case to diagnosis of a secondary case.
We extended the Wallinga and Teunis method to allow the diagnosis interval to vary
according to the time of diagnosis of the index case, and to allow for the possibility that the
diagnosis interval can be negative, because it is possible that individuals may have been infected
by index cases who had not yet been diagnosed. The likelihood that case i has been infected by
case j is decomposed into the product of the likelihood that the index case of i has been diag-
nosed and the relative likelihood that if the index case of i has been diagnosed, it is a particular
individual j. The relative likelihood that case i has been infected by case j (rather than by
another case diagnosed up to year T, here T = 2010) is given by
pij ¼
wtjðti  tjÞX
k;k 6¼i
wtkðti  tkÞ
ð1Þ
where wt(.) denotes the distribution of the diagnosis interval for index cases diagnosed in year
t.
The likelihood that case i has been infected by a case observed up to year T can be approxi-
mated by
qi ¼
XT
t¼0
wtðti  tÞ
Xþ1
t¼0
wtðti  tÞ
ð2Þ
assuming that the incidence of diagnosed cases is constant over time (see S1 Text). Additionally
assuming that the diagnosis interval distribution remains unchanged after T, this ratio simpli-
ﬁes to
qi ¼
XT
t¼0
wtðti  tÞ
XT
t¼0
wtðti  tÞ þ
XTþS
t¼Tþ1
wTðti  tÞ
ð3Þ
where S> 0 is the maximum possible negative diagnosis interval, such that for all u< −S and
wT(u) = 0, the total likelihood that a diagnosed case i has been infected by case j (rather than by
HIV-1 Transmission Dynamics
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another case, diagnosed or not) is given by
pij ¼ pij  qi ¼
wtjðti  tjÞX
k;k6¼i
wtkðti  tkÞ

XT
t¼0
wtðti  tÞ
XT
t¼0
wtðti  tÞ þ
XTþS
t¼Tþ1
wTðti  tÞ
: ð4Þ
Note that the derivation of qi assumes a constant incidence over time. Analyses presented in
S1 Text show how qi is modified when this assumption does not hold, and these analyses indi-
cate that the resulting estimates of the reproduction number show consistent temporal trends
regardless of the validity of this assumption, although the actual values may vary (S2 and S3
Figs).
The time-varying diagnosis interval wt(.) was obtained by numerically simulating a com-
partmental HIV transmission model previously fitted to HIV and AIDS diagnosis data on
MSM in the Netherlands, where it is assumed no transmission occurs when individuals are on
treatment (see S1 Text) [2]. This mathematical model was used to estimate the time-varying
diagnosis interval for the whole HIV epidemic amongst MSM, and not to directly fit to cluster
dynamics (see S1 Fig).
We further extended the Wallinga and Teunis method to incorporate uncertainty in the
number of individuals diagnosed in a certain year t, Dt. The ATHENA cohort records the num-
ber St of individuals diagnosed in year t who survived until 1996 and for whom a pol sequence
was available. Therefore, we assumed that Dt = Xt + St, with Xt*Negbin(St, 1−φt×πt), where
φt is the probability that an individual diagnosed in year t survives until 1996 (taken from [2])
and πt is the probability that the virus is sequenced (taken from the ATHENA records) given
survival up to 1996.
To estimate Rt for each cluster, we first sampled n = 50 realizations of Dt from this negative
binomial distribution. For each of these, we then sampled 50 possible transmission chains (for
each transmission chain, the index case of each secondary case i is sampled according to a mul-
tinomial distribution with probabilities pij), leading to a total of 2,500 likely transmission
chains. For each chain, we counted the number of secondary cases corresponding to each case,
and averaged over index cases diagnosed in the same year to get one Rt trajectory over time.
We pooled the 2,500 trajectories and used their mean and 2.5–97.5 quantiles as the point esti-
mate and 95% confidence interval of Rt. Before pooling, each Rt trajectory was corrected for
right censoring to account for the fact that some of the secondary cases of index cases diag-
nosed in year tmay not have been diagnosed yet, which may bias downwards the estimates of
Rt, with a stronger effect in recent years. To correct for this effect, Rt was divided by
X2010t
u¼S
wtðuÞ,
which represents the expected proportion of secondary cases of index cases diagnosed in year t
who should be diagnosed in or before 2010, should overall transmission rates remain constant.
Note that although this correction assumes that overall transmission rates will remain constant
in the future, it still allows for heterogeneity in the times at which secondary cases appear rela-
tive to a given index case. We performed a sensitivity analysis to check that this right censoring
correction was not introducing a systematic bias in the recent estimates of Rt (see S4 Fig).
Results
Study Population and Phylogenetic Tree
Characteristics of the ATHENA patients are shown in Table 1. Of the 5,852 patients with a
HIV-1 subtype B pol sequence in this study, 219 (4%) were registered in the cohort in Curaçao
HIV-1 Transmission Dynamics
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and 5,644 were registered in the Netherlands, of whom 4,288 (73%) reported being MSM, 207
(4%) reported being persons who inject drugs (PWID), and 849 (15%) reported being infected
via heterosexual contact. Of HIV-positive MSM registered in the Netherlands and diagnosed
before 1 January 1996, 35% (781/2,218) have a pol sequence included, versus 43% (3,507/8,247)
of those diagnosed since 1 January 1996. Overall, 48% of MSM registered in the cohort in the
Netherlands are treated in the capital city, Amsterdam, and account for 51% of the sequences
in this study; 25% of MSM are treated in the other big cities in the western part of the country
and account for 27% of the sequences. S7 Fig shows the phylogenetic tree of a total of 8,320
unique pol sequences, including sequences obtained from the Los Alamos HIV Sequence
Database.
Transmission Clusters
From the total phylogenetic tree, 106 large transmission clusters were identified that included
HIV pol sequences from10 patients from the ATHENA cohort, illustrated in Fig 2 stratified by
majority risk group of infection and cluster duration. The 106 clusters included 52% (3,061) of
sequences from 5,852 ATHENA patients and 652 sequences obtained from the Los Alamos HIV
Sequence Database. Only 15 of the 106 clusters were not MSM-majority clusters (50%MSM).
Of these, 11 clusters were dominated by heterosexually infected individuals of Suriname or Antil-
lean origin, one was dominated by PWID of Polish origin, and two were mixed heterosexual and
MSM clusters of mostly Dutch origin. The largest cluster included sequences from 136 (42%)
PWID—hence, from 66% of all PWID with a sequence in this study—and also included
sequences from 122 (37%) heterosexually infected individuals and from 24 (7%) MSM. It also
included 200 HIV pol sequences from the Los Alamos sequences. Fig 3 illustrates all clusters by
region of origin. See S1 Trees for timed trees of all clusters and S1 Text for more detailed informa-
tion on the largest PWID cluster and the transmission clusters circulating on Curaçao.
MSM-Majority Clusters
Fifty percent (2,128) of the 4,288 MSM registered in the ATHENA cohort in the Netherlands
with a sequence in this study were in 91 large MSM-majority (50%) transmission clusters
including at least10 patients from the ATHENA cohort. A further 28% (1,192) were in 417
small clusters containing 2–9 ATHENA sequences; 21% (900) were singletons, of whom 132
clustered solely with foreign sequences; and only 68 were in nine of the non-MSM-dominated
clusters (Fig 4). The median number of MSM registered in the cohort in the Netherlands per
large cluster was 16 (IQR 11–27, range 5–121).
At least 59% (54) of the 91 large MSM-majority clusters were already circulating before
1996 (Fig 4). Most clusters were confirmed in the BEAST analysis. Figs 2, 3, and 5 show the
estimated time of the MRCA of all clusters, and the 95% HPD intervals are in S2 Table. These
estimations indicate that 23 (95% HPD interval 8–33) of the clusters identified in or after 1996
(57%) might have started off before 1996, but also that 14 (95% HPD interval 4–29) of these
clusters started off more recently (Fig 4).
Of 3,460 MSM with a sequence in this study who were registered in the ATHENA cohort in
the Netherlands and diagnosed after 1996, 1,226 (35%) were infected within 54 transmission
clusters circulating before 1996, and 20% (700) within 37 large clusters identified in or after
1996; of the latter, 429 (95% HPD interval 272–621) were in clusters with a time of the MRCA
before 1996. Thus, in total, 48% (95% HPD interval 43%–53%) of these men diagnosed in or
after 1996 were infected within a cluster that started circulating in the Netherlands before
1996. The proportion of these men diagnosed in the 54 clusters identified before 1996
increased over time to 42% in 2010; the proportion in either these clusters or clusters identified
HIV-1 Transmission Dynamics
PLOSMedicine | DOI:10.1371/journal.pmed.1001898 November 3, 2015 9 / 25
HIV-1 Transmission Dynamics
PLOSMedicine | DOI:10.1371/journal.pmed.1001898 November 3, 2015 10 / 25
since 1996 but with a time of the MRCA before 1996 increased to 55% (95% HPD interval
53%–62%). Those diagnosed within any of the large clusters increased to 68% (Fig 4).
Recent infections. Of the 54 pre-1996 clusters, 78% (40) included recent infections after
2000 (Fig 5). Since 1996, a recent infection at diagnosis could be identified amongst 41% of
MSM in large clusters, 31% of MSM in smaller clusters, and 22% of MSM singletons. Only
three (6%) of the 54 pre-1996 clusters had no new diagnoses observed in the last 5 y of the
study period, 2006–2010.
Country of infection. Amongst 3,416 MSM registered in the ATHENA cohort in the
Netherlands with a sequence in this study who reported a most likely country of infection,
4.3% of MSM in large clusters reported likely having been infected abroad, and likewise 8.1%
(risk ratio [RR] = 1.9; 95% CI 1.4–2.6) in smaller clusters, 19.0% (RR = 4.5; 95% CI 3.4–5.9) of
singletons, and 27.8% (RR = 6.5; 95% CI 4.4–9.7) of MSM clustering solely with one or more
Los Alamos sequences. This indicates that singletons, besides being part of unidentified clusters
of national transmission, often represent new introductions.
Data versus theory. Fig 4 illustrates that only a small minority (7%) of all the observed
phylogenetic MSM clusters (sum of singletons and small and large clusters) were established
“large” transmission clusters including ten or more cases. This is broadly consistent with results
from branching theory, which indicates that this proportion should be between 6% and 35%
for a reproduction number between 0.8 and 1.2 (see S1 Text). Theoretical results also show that
this observed proportion is a good approximation for the proportion of introductions leading
to sub-epidemics of ten cases or more, with little sensitivity to the proportion of cases whose
virus was sequenced.
Estimation of the Case Reproduction Number within Large
MSM-Majority Transmission Clusters
Fig 6 shows the estimated annual case reproduction number for all 91 large MSM-majority
transmission clusters. With a reproduction number around one (the critical value that sepa-
rates epidemic spread from contraction), clusters were self-sustaining over the whole study
period. Reproduction numbers were strikingly consistent across clusters. A tendency towards
higher numbers was visible over recent years, especially in the more recently introduced clus-
ters (see S6 Fig). Seventy-five percent (68) of the clusters had a mean reproduction number
greater than one over the last 5 y (Fig 2).
Sensitivity Analysis
With the looser cluster definition, 105 large MSM-majority clusters were selected, containing
69% (2,977) of the HIV pol sequences fromMSM registered in the ATHENA cohort in the
Fig 2. Large transmission clusters over time: risk group of infection. The picture illustrates the
distribution of 106 large transmission clusters, where every horizontal line of dots represents one cluster, and
each dot represents a single patient in the cluster by the year of diagnosis. The dots in a cluster represent in
total 52% (3,061) of 5,852 ATHENA patients with a HIV-1 subtype B pol sequence in this study. The clusters
are ordered by majority risk group and by the number of years between the first and last patient identified
within each particular cluster. The color of each dot represents the self-reported risk group of infection. X’s
indicate the estimated time of the MRCA, in orange for Curaçao. Some discrepancies may arise as the
earliest cases sometimes are included with a sequence many years after their year of diagnosis. On the right-
hand side the estimated mean reproduction number over the last 5 y is indicated. At the bottom of the figure,
patients are represented who could not be identified as belonging to a cluster. The group above this one
shows those patients who belonged to clusters in the phylogenetic tree with fewer than 10 ATHENA
sequences included, which were not regarded as large clusters according to our definition. S8 Fig shows the
same figure with also these smaller clusters stratified by duration. HT, heterosexual transmission.
doi:10.1371/journal.pmed.1001898.g002
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Netherlands, and only 4% (183) of sequences were singletons. In this sensitivity analysis, 17%
of all observed phylogentic MSM clusters (including the singletons) included ten or more
cases. With the more stringent cluster definition, 67 clusters were identified, containing 39%
(1,670) of the pol sequences fromMSM registered in the cohort in the Netherlands. With clus-
ters defined under the single linkage branch length threshold, 63 large MSM-majority clusters
were selected, containing 69% (2,974) of the pol sequences fromMSM registered in the cohort
in the Netherlands. In this analysis also, only a small minority (5%) of all observed phylogentic
MSM clusters included ten or more cases. The estimations of the case reproduction number for
the large MSM-majority clusters in all three sensitivity analyses were similar to those in our
main analysis (Fig 6).
Age of MSM at Diagnosis
Fig 7 shows that the HIV epidemic is shifting from the initially infected generations of MSM
towards younger generations. The mean age at diagnosis of MSM in our study has been
increasing by 0.31 years per calendar year overall. However, this overall trend hides more com-
plicated dynamics because within each of the 91 large MSM-majority clusters, the mean age at
diagnosis has increased more rapidly, at a rate of 0.45 years/year, compared to the epidemic as
a whole. On the other hand, new clusters have started with a lower initial mean age, which,
across clusters, has increased at rate of only 0.28 years/year.
Discussion
This study provides insight into the different transmission clusters that have contributed to the
ongoing resurgent HIV epidemic amongst MSM in the Netherlands. We found that clusters
that started spreading before the introduction of cART in 1996 still constitute the main source
for new HIV-1 subtype B infections (~55% in 2010). Calculations of the reproduction number
separately for each cluster show that whilst the epidemic diminished at the population level
during the 1990s [1,2,10], most of these clusters continued spreading in a self-sustaining man-
ner. There is little indication that any of the clusters will stop in the near future as most clusters
contain recent infections and are rejuvenated by the inclusion of younger men, and many have
a reproduction number greater than the epidemic threshold. While all clusters appear to be
aging, new clusters appear to be of lower mean age; if anything, these “younger” clusters have
higher epidemic potential than the “older” clusters. It is also conceptually interesting to see the
whole HIV-1 subtype B epidemic disaggregated in a single figure (Figs 2 and 3). This perspec-
tive illustrates the tight links between clusters on Curaçao with people from the same region
living in the Netherlands [19,30–32]. It also shows that the largest transmission cluster, which
is dominated by PWID, shows links to heterosexual transmission but is an almost entirely sep-
arate epidemic from that amongst MSM.
The median reproduction number of all large clusters together found in this study is consis-
tent with our previous findings of the HIV epidemic amongst MSM in that it is around the epi-
demic threshold and increases in later years. However, our previous study reported the mean
reproduction number aggregated over the whole epidemic, whilst our findings here are based
on disaggregating the epidemic into its constituent sub-epidemics. We found that the resurgent
epidemic is the result of existing transmission clusters, many of which have been spreading
since the early epidemic, to which new transmission clusters are being added. There seems to
Fig 3. Large transmission clusters over time: region of origin. As in Fig 2, but here the color of each dot
represents the region of origin. In large MSM-majority clusters 79% (1,673) of MSMwere of Dutch origin. HT,
heterosexual transmission.
doi:10.1371/journal.pmed.1001898.g003
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be a high and continued rate of case importation, but with only a small minority of cases going
on to establish new self-sustaining clusters (Fig 5). This heterogeneity of outcomes is in line
Fig 4. Diagnosis and growth of transmission clusters over time. Cluster types within the phylogenetic tree are defined as follows. Singletons (in blue) are
clusters of size 1, or cases whose sequence solely clustered with sequences from the Los Alamos HIV Sequence Database. Small clusters (in green)
comprise sequences from 2–9 ATHENA patients. Large clusters comprise sequences from ten or more patients in the ATHENA cohort. Amongst those, non-
MSM-dominant clusters (in brown) contain a majority of sequences from non-MSM patients, whilst MSM-majority clusters contain a majority of sequences
fromMSM patients. Among large MSM-majority clusters, pre-1996 clusters (in dark orange) are defined as those in which the first diagnosed patient in the
cluster was diagnosed before 1996, and post-1996 clusters are defined as those in which all patients in the cluster were diagnosed in or after 1996. Large
MSM-majority post-1996 clusters are stratified as “time of MRCA pre-1996” (in light orange) when the estimated time of the MRCA is before 1996, and “time
of MRCA post-1996” (in purple) when the estimated time of the MRCA is in or after 1996. (A) Number of MSM registered in the ATHENA cohort in the
Netherlands with a sequence in this study by year of diagnosis and by cluster type. (B) Number of clusters of each type by year of first diagnosed case in
each cluster.
doi:10.1371/journal.pmed.1001898.g004
HIV-1 Transmission Dynamics
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Fig 5. Large transmission clusters over time: recent infections. As in Fig 2, but here red dots represent
patients with a documented recent infection. HT, heterosexual transmission.
doi:10.1371/journal.pmed.1001898.g005
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with expectations from epidemiological theory, as we also show in S1 Text: self-sustaining sub-
epidemics are hard to establish but, once initiated, are difficult to stop [33]. The higher percent-
age of recent infections in large clusters versus small clusters and singletons could indicate an
effect of partner tracing. Several studies indicated that a large part of onward transmission
amongst MSM is during the early phase of infection [11,34–37]. And thus it is worrying that
even though an increasing number of MSM with HIV are diagnosed early in infection, this
does not seem to have stopped clusters from growing.
The clusters and findings were confirmed using different phylogenetic methods and cluster
definitions. However, by phylogenetic methods alone and using only pol sequences of only a
subset of patients, we were not able to fully identify all transmission chains. The focus in our
Fig 6. Estimated case reproduction number over time for all MSM-majority transmission clusters of10 cases. The solid lines show the mean Rt
estimate for each transmission cluster. The bold black line is the mean Rt of all clusters, with the 95% confidence interval shown by the dotted lines. The
shaded areas show the 95% confidence intervals for each transmission cluster: darker areas indicate overlapping intervals across different transmission
clusters. Transmission clusters are shown in red if their first sequence appeared before 1991, in blue if their first sequence appeared between 1991 and
2000, and in green if their first diagnosed case appeared after 2000. The black horizontal dotted line represents the threshold value Rt = 1. (A) Main analysis.
(B) Sensitivity analysis for a looser cluster definition. (C) Sensitivity analysis for a more stringent cluster definition. (D) Sensitivity analysis for the clusters
defined under a single linkage branch length threshold.
doi:10.1371/journal.pmed.1001898.g006
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study was on the large transmission clusters. The observation that sequences from patients
diagnosed before 1996 were less often part of a large cluster could indicate that some initial
clusters have stopped circulating and have gone unnoticed. It is also possible that, since the
sample fraction was lower in early years, fewer individuals appear to cluster (due to missing
links), even though they were in fact linked to larger transmission clusters via unknown
intermediates.
Our estimates of the reproduction number are based on a number of assumptions, including
that the distribution of the diagnosis interval (time from diagnosis of an index case to diagnosis
of a secondary case) is similar across clusters and similar across the whole HIV-positive popu-
lation in the Netherlands. These estimates also assume that the probability of having a
sequence obtained and the probability of surviving until 1996 are similar across clusters. It
should be noted that the reproduction numbers estimated in this study are effective reproduc-
tion numbers. Our findings might thus indicate local or temporal saturation effects in certain
sexual networks. However, as prevalence of HIV amongst MSM ranges from 5% to 8% [38],
behavior change, not saturation, is expected to be the dominant driver of epidemic trends in
this population. For a future study it would be interesting to compare findings, from real and
simulated data, with recent studies that obtained reproduction numbers for large transmission
clusters directly from sequence data [13,14].
This study, combining phylogenetic methods with mathematical modeling to analyze exten-
sive HIV-1 subtype B sequence data, provides new insight into how different transmission net-
works together contribute to the resurgent HIV epidemic in the Netherlands. The analysis
suggests that the epidemic amongst MSM is dispersed amongst a large number of self-sustain-
ing or growing transmission clusters, many of which persisted throughout the 1990s, before
increases in risk behavior became widespread. In particular, the relative homogeneity and con-
sistency of reproduction number estimates for the different networks was unexpected. Our
study highlights that many different sub-epidemics have independently persisted for decades,
despite the widespread availability of treatment, steadily increasing rates of diagnosis, and
increasing tendency for early treatment initiation. The fastest growing sub-epidemics are the
Fig 7. Proportional contribution of new HIV-1 diagnoses amongst all MSM in the ATHENA cohort by decade of birth.
doi:10.1371/journal.pmed.1001898.g007
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newest ones, which also tend to be amongst the youngest men. Preventing further increases in
rates of infection will require further developments in prevention services.
Supporting Information
S1 Fig. Distribution of the diagnosis interval stratified by year of diagnosis of the index
case.
(PDF)
S2 Fig. qi as a function of time in different scenarios regarding incidence growth over time.
The black line shows the scenario with constant incidence over time, which was considered in
the main text.
(PDF)
S3 Fig. Influence of assumptions underlying qi derivation on the estimates of yearly repro-
duction numbers R for the four largest transmission clusters.
(PDF)
S4 Fig. Estimated case reproduction number over time for all MSM-majority transmission
clusters with10 cases diagnosed before 2000. The solid lines show the mean Rt estimates
for each transmission cluster using the dataset truncated after 2000 (black lines) and using the
full dataset (blue lines). The shaded areas show the 95% confidence intervals for each transmis-
sion cluster (black shading for the dataset truncated after 2000, blue shading for the full data-
set). The red horizontal line represents the threshold value Rt = 1.
(PDF)
S5 Fig. Comparison of Rt in different time periods.
(PDF)
S6 Fig. Increasing Rt. (A) Number of cases in the first 5 y of each cluster and overall sample
fraction. (B) Rate of increase in the mean estimated Rt over the first 5 y for each cluster.
(PDF)
S7 Fig. Phylogenetic tree of a total of 8,320 HIV-1 subtype B pol sequences. Branches corre-
sponding to the 5,852 ATHENA patients are colored by self-reported risk group of infection.
HT, heterosexual transmission.
(PDF)
S8 Fig. Large transmission clusters over time. As in Fig 2A, but including the small clusters
including 2–9 ATHENA sequences sorted by duration.
(PDF)
S9 Fig. Timed tree of HIV-1 pol sequences from patients in the six largest clusters on Cura-
çao. (A) Branches are colored according to region of residence. (B) Branches are colored
according to the self-reported risk group of infection. The root of each cluster is indicated in
bold. HT, heterosexual transmission.
(PDF)
S10 Fig. Observed and expected proportion of singletons and small clusters. Under the
Poisson (left) and geometric (right) model. The top three rows show how these proportions
change as a function of π, the proportion of cases with a sequence, for a mean number of off-
spring of R = 1, R = 0.9, and R = 1.1, respectively. The vertical red dotted lines indicate the
observed proportion of cases with a sequence, π = 0.3 over the whole time period considered.
The bottom row shows how the proportions of singletons and small clusters change as a
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function of R, the mean number of offspring, for a proportion of cases with a sequence of π =
0.3. In all plots, the black and grey curves show the expected and observed proportion of single-
tons, respectively, with dotted lines indicating confidence intervals around the observed pro-
portion; the dark and light blue curves show the expected and observed proportion of small
clusters (size 2–9), with dashed lines indicating confidence intervals around the observed pro-
portion.
(PDF)
S1 Table. Phylogenetic trait association test on structuring within the largest HIV-1 sub-
type B transmission cluster in the Netherlands. To test whether HIV-1 pol sequences in the
last 1,000 posterior trees obtained by BEAST were structured more strongly by risk group for
the ATHENA sequences and more strongly by country for the sequences from the Los Alamos
HIV Sequence Database [18] than expected by chance alone, a phylogenetic trait association
analysis using Bayesian tip-association significance testing was performed [39]. The maximum
monophyletic clade (MC) size statistic was estimated for each trait, which provides an estimate
of the mean cluster size of sequences sampled for each trait. Significant clustering is defined as
critical (p< 0.01), marginally significant (0.01 p 0.05), or not significant (p> 0.05).
(PDF)
S2 Table. Time of the MRCA and 95% HPD intervals of the 91 large majority MSM phylo-
genetic clusters.
(XLS)
S1 Text. Supporting information on methods, sensitivity analysis, and results.
(PDF)
S1 Trees. Timed trees of 91 MSM-majority clusters. The first number of the branch name is
the cluster name. Bars indicate the 95% HPD intervals of the node ages. In total, 380 of the Los
Alamos sequences selected are included in the 91 large MSM-majority clusters. Twenty-six
clusters have no Los Alamos sequences included. Nine clusters include5 time-stamped
sequences from a particular country (Foreign). Although some mixing is visible, these
sequences form mainly separate clusters within the respective countries. Timed tree of the 15
other clusters (Other): four clusters with a majority of patients of Suriname origin, three clus-
ters with a majority of patients of Antillean origin, two clusters of heterosexually infected indi-
viduals and MSM of mainly Dutch origin, one cluster with mainly PWID of Polish origin, the
largest PWID cluster, and the six clusters on Curaçao with bars (two are also in MSM).
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Kinderziekenhuis, Amsterdam: HIV nurse consultants: A. van der Plas, A. M. Weijsenfeld.
Erasmus Medisch Centrum, Rotterdam: HIV treating physicians: M. E. van der Ende, T. E.
M. S. de Vries-Sluijs, E. C. M. van Gorp, C. A. M. Schurink, J. L. Nouwen, A. Verbon, B. J. A.
Rijnders, H. I. Bax, R. J. Hassing, M. van der Feltz. HIV nurse consultants: N. Bassant, J. E. A.
van Beek, M. Vriesde, L. M. van Zonneveld. Data collection: A. de Oude-Lubbers, H. J. van den
Berg-Cameron, F. B. Bruinsma-Broekman, J. de Groot, M. de Zeeuw- de Man.HIV clinical
virologists/chemists: M. Schutten, A. D. M. E. Osterhaus, C. A. B. Boucher. Erasmus Medisch
Centrum–Sophia, Rotterdam: HIV treating physicians: G. J. A. Driessen, A. M. C. van Ros-
sum. HIV nurse consultants: L. C. van der Knaap, E. Visser. Flevoziekenhuis, Almere:HIV
treating physicians: J. Branger. HIV nurse consultants/data collection: C. J. H. M. Duijf-van de
Ven.HagaZiekenhuis, Den Haag: HIV treating physicians: E. F. Schippers, C. van Nieuw-
koop, R. W. Brimicombe. HIV nurse consultants: J. M. van IJperen. Data collection: G. van der
Hut. HIV clinical virologists/chemists: P. F. H. Franck.HIV Focus Centrum (DC Klinieken),
Amsterdam: HIV treating physicians: A. van Eeden.HIV nurse consultants: W. Brokking, M.
Groot, L. J. M. Elsenburg. HIV clinical virologists/chemists: M. Damen, I. S. Kwa. Isala Klinie-
ken, Zwolle: HIV treating physicians: P. H. P. Groeneveld, J. W. Bouwhuis.HIV nurse consul-
tants: J. F. van den Berg, A. G. W. van Hulzen. Data collection: G. L. van der Bliek, P. C. J. Bor.
HIV clinical virologists/chemists: P. Bloembergen, M. J. H. M. Wolfhagen, G. J. H. M. Ruijs.
Leids Universitair Medisch Centrum, Leiden: HIV treating physicians: F. P. Kroon, S. M.
Arend, M. G. J. de Boer, M. P. Bauer, H. Jolink, A. M. Vollaard.HIV nurse consultants: W. Dor-
ama, N. van Holten. HIV clinical virologists/chemists: E. C. J. Claas, A. C. M. Kroes.Maasstad
Ziekenhuis, Rotterdam: HIV treating physicians: J. G. den Hollander, K. Pogany.HIV nurse
consultants: M. Kastelijns, J. V. Smit, E. Smit. Data collection: M. Bezemer, T. van Niekerk. HIV
clinical virologists/chemists: O. Pontesilli.Maastricht UMC+, Maastricht: HIV treating physi-
cians: S. H. Lowe, A. Oude Lashof, D. Posthouwer. HIV nurse consultants: R. P. Ackens, J.
Schippers, R. Vergoossen. Data collection: B. Weijenberg Maes. HIV clinical virologists/chem-
ists: P. H. M. Savelkoul, I. H. Loo.Medisch Centrum Slotervaart, Amsterdam: HIV treating
physicians: J. W. Mulder, S. M. E. Vrouenraets, F. N. Lauw. HIV nurse consultants: M. C. van
Broekhuizen, H. Paap, D. J. Vlasblom. Data collection: E. Oudmaijer Sanders. HIV clinical
virologists/chemists: P. H. M. Smits, A. W. Rosingh.Medisch Centrum Zuiderzee, Lelystad:
HIV treating physicians: S. Weijer, R. El Moussaoui.HIV nurse consultant: A. S. Bosma.Med-
isch Centrum Alkmaar, Alkmaar: HIV treating physicians: W. Kortmann, G. van Twillert, J.
W. T. Cohen Stuart, B. M. W. Diederen.HIV nurse consultants/data collection: D. Pronk, F. A.
van Truijen-Oud. HIV clinical virologists/chemists: W. A. van der Reijden, R. Jansen.Medisch
Centrum Haaglanden, Den Haag: HIV treating physicians: E. M. S. Leyten, L. B. S. Gelinck.
HIV nurse consultants: A. van Hartingsveld, C. Meerkerk, G. S. Wildenbeest. HIV clinical virol-
ogists/chemists: J. A. E. M. Mutsaers, C. L. Jansen.Medisch Centrum Leeuwarden, Leeuwar-
den:HIV treating physicians: M. G. A. van Vonderen, D. P. F. van Houte, L. M. Kampschreur.
HIV nurse consultants: K. Dijkstra, S. Faber.HIV clinical virologists/chemists: J. Weel.Medisch
Spectrum Twente, Enschede: HIV treating physicians: G. J. Kootstra, C. E. Delsing. HIV
nurse consultants: M. van der Burg-van de Plas, H. Heins. Data collection: E. Lucas.Onze Lieve
Vrouwe Gasthuis, Amsterdam: HIV treating physicians: K. Brinkman, P. H. J. Frissen, W. L.
Blok, W. E. M. Schouten, G. E. L. van den Berk. HIV nurse consultants: C. J. Brouwer, G. F.
Geerders, K. Hoeksema, M. J. Kleene, I. B. van der Meché, A. J. M. Toonen, S. Wijnands. HIV
clinical virologists/chemists: M. L. van Ogtrop, R. Jansen. Radboudumc, Nijmegen: HIV treat-
ing physicians: P. P. Koopmans, M. Keuter, A. J. A. M. van der Ven, H. J. M. ter Hofstede, A. S.
HIV-1 Transmission Dynamics
PLOSMedicine | DOI:10.1371/journal.pmed.1001898 November 3, 2015 20 / 25
M. Dofferhoff, R. van Crevel.HIV nurse consultants: M. Albers, M. E. W. Bosch, K. J. T.
Grintjes-Huisman, B. J. Zomer. HIV clinical virologists/chemists: F. F. Stelma.HIV clinical
pharmacology consultant: D. Burger. Rijnstate, Arnhem: HIV treating physicians: C. Richter,
J. P. van der Berg, E. H. Gisolf. HIV nurse consultants: G. ter Beest, P. H. M. van Bentum, N.
Langebeek. HIV clinical virologists/chemists: R. Tiemessen, C. M. A. Swanink. Sint Lucas
Andreas Ziekenhuis, Amsterdam:HIV treating physicians: J. Veenstra, K. D. Lettinga. HIV
nurse consultants: M. Spelbrink, H. Sulman. Data collection: M. Spelbrink, E. Witte. HIV clini-
cal virologists/chemists: M. Damen, P. G. H. Peerbooms. Spaarne Gasthuis, Haarlem: HIV
treating physicians: S. F. L. van Lelyveld, R. Soetekouw. HIV nurse consultants: N. Hulshoff, L.
M. M. van der Prijt, J. van der Swaluw. Data collection: N. Bermon. HIV clinical virologists/
chemists: W. A. van der Reijden, R. Jansen, B. L. Herpers, D. Veenendaal. Stichting Medisch
Centrum Jan van Goyen, Amsterdam:HIV treating physicians: D. W. M. Verhagen.HIV
nurse consultants: J. Geilings. St Elisabeth Ziekenhuis, Tilburg: HIV treating physicians: M. E.
E. van Kasteren, A. E. Brouwer.HIV nurse consultants/data collection: B. A. F. M. de Kruijf-
van de Wiel, M. Kuipers, R. M. W. J. Santegoets, B. van der Ven. HIV clinical virologists/chem-
ists: J. H. Marcelis, A. G. M. Buiting, P. J. Kabel. Universitair Medisch Centrum Groningen,
Groningen: HIV treating physicians: W. F. W. Bierman, H. G. Sprenger, E. H. Scholvinck, S.
van Assen, K. R. Wilting, Y. Stienstra.HIV nurse consultants: H. de Groot-de Jonge, P. A. van
der Meulen, D. A. de Weerd.HIV clinical virologists/chemists: H. G. M. Niesters, A. Riezebos-
Brilman, C. C. van Leer-Buter. Universitair Medisch Centrum Utrecht, Utrecht: HIV treating
physicians: A. I. M. Hoepelman, M. M. E. Schneider, T. Mudrikova, P. M. Ellerbroek, J. J. Oos-
terheert, J. E. Arends, R. E. Barth, M. W. M. Wassenberg. HIV nurse consultants: D. H. M. van
Elst-Laurijssen, E. E. B. van Oers-Hazelzet, J. Patist, S. Vervoort, Data collection: H. E. Nieu-
wenhuis, R. Frauenfelder.HIV clinical virologists/chemists: R. Schuurman, F. Verduyn-Lunel,
A. M. J. Wensing. VUMedisch Centrum, Amsterdam: HIV treating physicians: E. J. G.
Peters, M. A. van Agtmael, M. Bomers, J. de Vocht. HIV nurse consultants: M. Heitmuller, L.
M. Laan. HIV clinical virologists/chemists: A. M. Pettersson, C. M. J. E. Vandenbroucke-Grauls,
C. W. Ang.Wilhelmina Kinderziekenhuis, University Medical Center Utrecht, Utrecht:
HIV treating physicians: S. P. M. Geelen, T. F. W. Wolfs, L. J. Bont. HIV nurse consultants: N.
Nauta. St. Elisabeth Hospitaal, Willemstad, Curaçao: HIV treating physicians: C. Winkel, A.
Durand, F. Muskiet, R. Voigt. HIV nurse consultants: I. van der Meer.
Coordinating Center. Stichting HIVMonitoring: Director: P. Reiss. Data analysis: D. O.
Bezemer, L. Gras, A. I. van Sighem, C. Smit. Data management and quality control: S. Zaheri,
M. Hillebregt, A. de Jong. Data monitoring: D. Bergsma, P. Hoekstra, A. de Lang, M. Berkhout,
S. Grivell, A. Jansen, M. J. Rademaker, M. Raethke. Data collection: L. de Groot, M. van den
Akker, Y. Bakker, M. Broekhoven, E. Claessen, A. El Berkaoui, E. Kruijne, C. Lodewijk, R. Mei-
jering, L. Munjishvili, B. Peeck, C. Ree, R. Regtop, Y. Ruijs, M. Schoorl, S. Schnörr, E. Tuijn, L.
Veenenberg, S. van der Vliet, T. Woudstra. Patient registration: B. Tuk.
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Editors' Summary
Background
Since the first recorded case of AIDS in 1981, the number of people infected with HIV, the
virus that causes AIDS, has risen steadily. Now, three and a half decades later, about 35
million people (more than half of whom are women) are infected with HIV, the virus that
causes AIDS. HIV is most often spread by having unprotected sex with an infected part-
ner, and, globally, most sexual transmission of HIV occurs during heterosexual sex. Never-
theless, many new HIV infections still occur in men who have sex with men (MSM;
homosexual, bisexual, and transgender men, and heterosexual men who sometimes have
sex with men), and, in some countries, HIV/AIDS still predominantly affects the MSM
community. In the US, for example, 78% of new HIV infections occurred among MSM in
2010 although MSM represent only 4% of the total population, and, in 2011, 54% of all
people living with HIV were MSM. Indeed, despite HIV-positive individuals being diag-
nosed earlier these days and having access to effective combination antiretroviral therapy
(cART), which both halts disease progression and reduces the risk of HIV transmission,
the HIV epidemic among MSM is resurgent (growing again) in many Western countries.
WhyWas This Study Done?
To control this resurgent epidemic, it is important to know as much as possible about HIV
transmission among MSM so that effective prevention strategies can be designed. Here,
the researchers use phylogenetic analysis and mathematical modeling to ask whether the
introduction of new strains or the spread of already circulating strains is responsible for
the resurgent HIV-1 subtype B epidemic occurring among MSM in the Netherlands. Viral
phylogenetic analysis infers evolutionary relationships between viral strains by examining
their genetic relatedness and can be used to identify HIV transmission clusters. HIV-1
viruses are classified into subtypes based on their genetic sequence and geographical distri-
bution. HIV-1 subtype B is a common subtype that is found in west and central Europe,
the Americas, and several other regions.
What Did the Researchers Do and Find?
The researchers built a phylogenetic tree for the HIV epidemic in MSM in the Netherlands
by analyzing HIV-1 subtype B polymerase gene sequences found in 5,852 participants
(73% of whom were MSM) in the ATHENA cohort, an observational cohort of all HIV-1-
infected patients in care in the Netherlands since 1996 (when cART became available).
Examination of this tree identified 106 large transmission clusters (groups of ten or more
closely related subtype B HIV-1 strains). Half of the HIV-1 polymerase sequences from
HIV-1-positive MSM registered in the ATHENA cohort in the Netherlands were included
in 91 MSM-majority clusters: large transmission clusters in which more than half the
related sequences originated fromMSM. At least 54 of the MSM-majority clusters were
circulating before 1996 and have persisted until the present day. Moreover, about a third
of new HIV infections diagnosed among MSM since 1996 involve viruses included in
these long-lived clusters. The researchers then used mathematical modeling to estimate
that the effective reproduction number (the number of secondary infections per primary
infection) for all the MSM-majority clusters was around one for the whole study period.
Thus, these clusters were self-sustaining and not contracting. Notably, MSM-majority
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clusters (particularly the newer clusters) tended to have higher reproduction numbers in
recent years. Moreover, although the average age at diagnosis within each of the MSM-
majority clusters increased over the study period at a rate of 0.45 years/year, the average
age at diagnosis was lower at initiation of new clusters and only increased by 0.28 years/
year.
What Do These Findings Mean?
These findings suggest that several large, persistent, and self-sustaining sub-epidemics,
many of which have been present since early in the AIDS epidemic, are driving the resur-
gent HIV epidemic among MSM in the Netherlands, despite the widespread availability of
treatment, increasing rates of diagnosis, and earlier treatment initiation. Importantly,
however, these findings also suggest that some sub-epidemics have emerged more recently
and that some sub-epidemics, particularly the newer ones, are growing and may be prefer-
entially affecting younger MSM. The accuracy of these findings may be limited by some
aspects of the study. For example, the reproduction number estimates assume that the
time from diagnosis of a case to the diagnoses of secondary cases is similar across clusters.
Nevertheless, the new insights provided by this study should help guide the development
of strategies to curb the resurgent HIV epidemic that is currently affecting MSM in the
Netherlands and elsewhere.
Additional Information
This list of resources contains links that can be accessed when viewing the PDF on a device
or via the online version of the article at http://dx.doi.org/10.1371/journal.pmed.1001898.
• The US Centers for Disease Control and Prevention provides information on all aspects
of HIV/AIDS, including information on HIV/AIDS among MSM (in English and
Spanish)
• NAM/aidsmap provides basic information about HIV/AIDS and summaries of recent
research findings, including information on HIV and MSM and personal stories from
MSM living with HIV
• Information is available from Avert, an international AIDS charity on many aspects of
HIV/AIDS, including MSM and HIV; Avert also provides personal stories about living
with HIV/AIDS
• TheWorld Health Organization provides information on all aspects of HIV/AIDS,
including HIV/AIDS and MSM (in several languages)
• The UNAIDS Fast-Track Strategy to End the AIDS Epidemic by 2030 provides up-to-
date information about the AIDS epidemic and efforts to halt it
• A 2011 World Bank Report The Global HIV Epidemics among Men Who Have Sex with
Men is available
• A PLOS Computational Biology Topic Page (a review article that is a published copy of
record of a dynamic version of an article in Wikipedia) about viral phylodynamics is
available
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